regorafenib
(FNHKPVJBJVTLMP-UHFFFAOYSA-N)
Structure
- SMILES
- CNC(=O)c1nccc(c1)Oc1ccc(c(c1)F)NC(=O)Nc1ccc(c(c1)C(F)(F)F)Cl
- Type(s)
- Approved
- ATC code(s)
- L01XE21
- Molecular Formula:
- C21H15ClF4N4O3
- Molecular Weight:
- 482.815
- Log P:
- 6.2257
- Hydrogen Bond Acceptor:
- 7
- Hydrogen Bond Donor:
- 3
- TPSA:
- 92.35
- CAS Number(s):
- 755037-03-7; 835621-08-4
Synonym(s)
1.
regorafenib
2.
4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)-3-fluorophenoxy)-n-methylpyridine-2-carboxamide
3.
BAY 73-4506
4.
BAY-73-4506
5.
BAY73-4506
6.
Stivarga
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Fatigue | FAERS: 661 Canada Vigilance: 192 | Canada Vigilance SIDER US FAERS | |
| 2 | Asthenia | FAERS: 359 Canada Vigilance: 72 | Canada Vigilance SIDER US FAERS | |
| 3 | Dysphonia | FAERS: 343 Canada Vigilance: 78 | Canada Vigilance SIDER US FAERS | |
| 4 | Nausea | FAERS: 287 Canada Vigilance: 40 | Canada Vigilance SIDER US FAERS | |
| 5 | Weight decreased | FAERS: 253 Canada Vigilance: 45 | Canada Vigilance SIDER US FAERS | |
| 6 | Vomiting | FAERS: 199 Canada Vigilance: 42 | Canada Vigilance SIDER US FAERS | |
| 7 | Dehydration | FAERS: 191 Canada Vigilance: 22 | Canada Vigilance US FAERS | |
| 8 | Pain | FAERS: 190 Canada Vigilance: 42 | Canada Vigilance SIDER US FAERS | |
| 9 | Headache | FAERS: 183 Canada Vigilance: 46 | Canada Vigilance SIDER US FAERS | |
| 10 | Abdominal Pain | FAERS: 171 Canada Vigilance: 34 | Canada Vigilance SIDER US FAERS | |
| 11 | Stomatitis | FAERS: 144 Canada Vigilance: 6 | Canada Vigilance SIDER US FAERS | |
| 12 | Malaise | FAERS: 143 Canada Vigilance: 30 | Canada Vigilance US FAERS | |
| 13 | Erythema | FAERS: 139 Canada Vigilance: 49 | Canada Vigilance US FAERS | |
| 14 | Constipation | FAERS: 133 Canada Vigilance: 49 | Canada Vigilance US FAERS | |
| 15 | Drug ineffective | FAERS: 132 Canada Vigilance: 57 | Canada Vigilance US FAERS | |
| 16 | Back Pain | FAERS: 107 Canada Vigilance: 32 | Canada Vigilance US FAERS | |
| 17 | Dry skin | FAERS: 94 Canada Vigilance: 35 | Canada Vigilance SIDER US FAERS | |
| 18 | Dizziness | FAERS: 93 Canada Vigilance: 14 | Canada Vigilance US FAERS | |
| 19 | General physical health deterioration | FAERS: 92 Canada Vigilance: 15 | Canada Vigilance US FAERS | |
| 20 | Disease Progression | FAERS: 89 Canada Vigilance: 11 | Canada Vigilance US FAERS | |
| 21 | Oral pain | FAERS: 88 Canada Vigilance: 24 | Canada Vigilance US FAERS | |
| 22 | Pneumonia | FAERS: 82 Canada Vigilance: 24 | Canada Vigilance US FAERS | |
| 23 | Peripheral swelling | FAERS: 81 Canada Vigilance: 19 | Canada Vigilance US FAERS | |
| 24 | Ascites | FAERS: 68 Canada Vigilance: 10 | Canada Vigilance US FAERS | |
| 25 | Chest Pain | FAERS: 66 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 26 | Hyperkeratosis | FAERS: 65 Canada Vigilance: 10 | Canada Vigilance US FAERS | |
| 27 | Arthralgia | FAERS: 62 Canada Vigilance: 19 | Canada Vigilance US FAERS | |
| 28 | Alopecia | FAERS: 57 Canada Vigilance: 5 | Canada Vigilance SIDER US FAERS | |
| 29 | Carcinoembryonic antigen increased | FAERS: 56 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 30 | Abasia | FAERS: 54 | US FAERS | |
| 31 | Myalgia | FAERS: 53 Canada Vigilance: 10 | Canada Vigilance US FAERS | |
| 32 | Urinary tract infection | FAERS: 52 Canada Vigilance: 18 | Canada Vigilance US FAERS | |
| 33 | Aspartate Aminotransferase Increased | FAERS: 49 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 34 | Drug dose omission | FAERS: 49 | US FAERS | |
| 35 | Oropharyngeal pain | FAERS: 49 Canada Vigilance: 12 | Canada Vigilance US FAERS | |
| 36 | Pruritus | FAERS: 45 Canada Vigilance: 11 | Canada Vigilance US FAERS | |
| 37 | Alanine Aminotransferase Increased | FAERS: 40 | SIDER US FAERS | |
| 38 | Burning sensation | FAERS: 40 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 39 | Sepsis | FAERS: 40 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 40 | Somnolence | FAERS: 39 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 41 | jaundice | FAERS: 39 Canada Vigilance: 10 | Canada Vigilance US FAERS | |
| 42 | Epistaxis | FAERS: 38 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 43 | Thrombocytopenia | FAERS: 38 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 44 | Hepatic Encephalopathy | FAERS: 37 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 45 | Hypotension | FAERS: 36 Canada Vigilance: 11 | Canada Vigilance US FAERS | |
| 46 | Product use in unapproved indication | FAERS: 36 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 47 | Therapy cessation | FAERS: 36 Canada Vigilance: 8 | Canada Vigilance US FAERS | |
| 48 | Aphonia | FAERS: 35 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 49 | Feeling abnormal | FAERS: 35 Canada Vigilance: 8 | Canada Vigilance US FAERS | |
| 50 | Proteinuria | FAERS: 34 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 51 | Pain of skin | FAERS: 33 Canada Vigilance: 8 | Canada Vigilance US FAERS | |
| 52 | Tremor | FAERS: 33 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 53 | Chills | FAERS: 32 Canada Vigilance: 8 | Canada Vigilance US FAERS | |
| 54 | Dyspepsia | FAERS: 31 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 55 | Intestinal Obstruction | FAERS: 31 Canada Vigilance: 10 | Canada Vigilance US FAERS | |
| 56 | Limb discomfort | FAERS: 31 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 57 | Hypophagia | FAERS: 30 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 58 | Abdominal discomfort | FAERS: 29 Canada Vigilance: 10 | Canada Vigilance US FAERS | |
| 59 | Aphagia | FAERS: 29 | US FAERS | |
| 60 | Malignant neoplasm progression | FAERS: 29 Canada Vigilance: 27 | Canada Vigilance US FAERS | |
| 61 | Infection | FAERS: 28 Canada Vigilance: 7 | Canada Vigilance SIDER US FAERS | |
| 62 | Urticaria | FAERS: 28 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 63 | Musculoskeletal Pain | FAERS: 27 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 64 | Myocardial Infarction | FAERS: 27 Canada Vigilance: 6 | Canada Vigilance SIDER US FAERS | |
| 65 | Chromaturia | FAERS: 25 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 66 | Disseminated Intravascular Coagulation | FAERS: 25 | US FAERS | |
| 67 | Dysgeusia | FAERS: 25 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 68 | Gait inability | FAERS: 25 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 69 | Product use issue | FAERS: 25 Canada Vigilance: 13 | Canada Vigilance US FAERS | |
| 70 | Disorientation | FAERS: 24 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 71 | Skin toxicity | FAERS: 24 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 72 | Anxiety | FAERS: 23 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 73 | Pancreatitis | FAERS: 23 | US FAERS | |
| 74 | Skin lesion | FAERS: 23 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 75 | Lethargy | FAERS: 22 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 76 | Bone pain | FAERS: 21 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 77 | Blood alkaline phosphatase increased | FAERS: 20 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 78 | Hypersomnia | FAERS: 20 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 79 | Rash erythematous | FAERS: 20 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 80 | Blood creatinine increased | FAERS: 19 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 81 | Blood potassium decreased | FAERS: 19 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 82 | Flatulence | FAERS: 19 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 83 | Joint swelling | FAERS: 19 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 84 | Ocular icterus | FAERS: 19 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 85 | Tachycardia | FAERS: 19 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 86 | Toxicity to various agents | FAERS: 19 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 87 | Transaminases increased | FAERS: 19 | US FAERS | |
| 88 | Urinary Retention | FAERS: 19 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 89 | Ammonia increased | FAERS: 18 | US FAERS | |
| 90 | Hepatotoxicity | FAERS: 18 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 91 | Atrial Fibrillation | FAERS: 17 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 92 | Blood lactate dehydrogenase increased | FAERS: 17 | US FAERS | |
| 93 | Chest discomfort | FAERS: 17 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 94 | Ileus | FAERS: 17 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 95 | Nasopharyngitis | FAERS: 17 Canada Vigilance: 12 | Canada Vigilance US FAERS | |
| 96 | Skin Ulcer | FAERS: 17 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 97 | Visual Impairment | FAERS: 17 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 98 | Cerebrovascular accident | FAERS: 16 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 99 | Hepatitis | FAERS: 16 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 100 | Musculoskeletal chest pain | FAERS: 16 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 101 | Productive Cough | FAERS: 16 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 102 | Therapy change | FAERS: 16 | US FAERS | |
| 103 | Blood count abnormal | FAERS: 15 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 104 | Blood pressure fluctuation | FAERS: 15 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 105 | Cerebral Infarction | FAERS: 15 | US FAERS | |
| 106 | Dysuria | FAERS: 15 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 107 | Hypothyroidism | FAERS: 15 | SIDER US FAERS | |
| 108 | Loss of personal independence in daily activities | FAERS: 15 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 109 | Skin reaction | FAERS: 15 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 110 | Blood glucose increased | FAERS: 14 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 111 | Discomfort | FAERS: 14 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 112 | Intentional product misuse | FAERS: 14 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 113 | Pulmonary Embolism | FAERS: 14 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 114 | Unevaluable event | FAERS: 14 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 115 | Blood urine present | FAERS: 13 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 116 | Gastrointestinal stromal cancer | FAERS: 13 | US FAERS | |
| 117 | Activities of daily living impaired | FAERS: 12 | US FAERS | |
| 118 | Acute kidney injury | FAERS: 12 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 119 | Blood magnesium decreased | FAERS: 12 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 120 | Cholecystitis | FAERS: 12 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 121 | Lymphadenopathy | FAERS: 12 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 122 | Pre-existing condition improved | FAERS: 12 | US FAERS | |
| 123 | White blood cell count decreased | FAERS: 12 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 124 | Wrong technique in product usage process | FAERS: 12 | US FAERS | |
| 125 | Adverse event | FAERS: 11 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 126 | Amnesia | FAERS: 11 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 127 | Bedridden | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 128 | Cancer Pain | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 129 | Delirium | FAERS: 11 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 130 | Epilepsy | FAERS: 11 | US FAERS | |
| 131 | Inflammation | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 132 | Influenza | FAERS: 11 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 133 | Memory impairment | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 134 | Nephrotic Syndrome | FAERS: 11 | US FAERS | |
| 135 | Therapeutic response unexpected | FAERS: 11 | US FAERS | |
| 136 | Anorectal discomfort | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 137 | Cholangitis | FAERS: 10 | US FAERS | |
| 138 | Gamma-Glutamyltransferase Increased | FAERS: 10 | US FAERS | |
| 139 | Hypersensitivity | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 140 | Musculoskeletal stiffness | FAERS: 10 Canada Vigilance: 4 | Canada Vigilance SIDER US FAERS | |
| 141 | Neck Pain | FAERS: 10 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 142 | Neutropenia | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 143 | Posterior reversible encephalopathy syndrome | FAERS: 10 | SIDER US FAERS | |
| 144 | Swelling | FAERS: 10 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 145 | Urinary Incontinence | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 146 | Blood albumin decreased | FAERS: 9 | US FAERS | |
| 147 | Bronchitis | FAERS: 9 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 148 | Early satiety | FAERS: 9 | US FAERS | |
| 149 | Feeling Cold | FAERS: 9 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 150 | Gastrointestinal Pain | FAERS: 9 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 151 | Inappropriate schedule of drug administration | FAERS: 9 | US FAERS | |
| 152 | Intentional product use issue | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 153 | Limb injury | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 154 | Metastasis | FAERS: 9 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 155 | Night sweats | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 156 | Palpitations | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 157 | Poor quality sleep | FAERS: 9 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 158 | Product dose omission | FAERS: 9 Canada Vigilance: 17 | Canada Vigilance US FAERS | |
| 159 | Acne | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 160 | Blood glucose decreased | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 161 | Cheilitis | FAERS: 8 | US FAERS | |
| 162 | Colon cancer recurrent | FAERS: 8 | US FAERS | |
| 163 | Deep Vein Thrombosis | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 164 | Depressed Level of Consciousness | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 165 | Mental impairment | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 166 | Musculoskeletal discomfort | FAERS: 8 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 167 | Neutrophil count decreased | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 168 | Nocturia | FAERS: 8 | US FAERS | |
| 169 | Oral candidiasis | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 170 | Performance status decreased | FAERS: 8 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 171 | Temperature intolerance | FAERS: 8 | US FAERS | |
| 172 | Thrombosis | FAERS: 8 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 173 | Blood creatine phosphokinase increased | FAERS: 7 | US FAERS | |
| 174 | Blood sodium decreased | FAERS: 7 | US FAERS | |
| 175 | Cachexia | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 176 | Diabetes Mellitus | FAERS: 7 | US FAERS | |
| 177 | Erythema Multiforme | FAERS: 7 | SIDER US FAERS | |
| 178 | Gastrointestinal motility disorder | FAERS: 7 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 179 | Hypertensive crisis | FAERS: 7 | SIDER US FAERS | |
| 180 | Intestinal Perforation | FAERS: 7 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 181 | Lipase increased | FAERS: 7 | SIDER US FAERS | |
| 182 | Mental status changes | FAERS: 7 | US FAERS | |
| 183 | Neuralgia | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 184 | Peritonitis | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 185 | Plantar erythema | FAERS: 7 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 186 | Product availability issue | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 187 | Skin Induration | FAERS: 7 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 188 | Stevens-Johnson Syndrome | FAERS: 7 | 25811541 | CTD SIDER US FAERS |
| 189 | Subileus | FAERS: 7 | US FAERS | |
| 190 | Syncope | FAERS: 7 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 191 | Abdominal tenderness | FAERS: 6 | US FAERS | |
| 192 | Altered state of consciousness | FAERS: 6 | US FAERS | |
| 193 | Blood potassium increased | FAERS: 6 | US FAERS | |
| 194 | Cataract | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 195 | Cholelithiasis | FAERS: 6 | US FAERS | |
| 196 | Cholestasis | FAERS: 6 | US FAERS | |
| 197 | Cystitis | FAERS: 6 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 198 | Diverticulitis | FAERS: 6 | US FAERS | |
| 199 | Gastrointestinal toxicity | FAERS: 6 | US FAERS | |
| 200 | Hepatomegaly | FAERS: 6 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 201 | Hospice Care | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 202 | Hydronephrosis | FAERS: 6 | US FAERS | |
| 203 | Hyperthyroidism | FAERS: 6 | US FAERS | |
| 204 | Large intestine perforation | FAERS: 6 | US FAERS | |
| 205 | Medical procedure | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 206 | Metastases to adrenals | FAERS: 6 | US FAERS | |
| 207 | Pneumonitis | FAERS: 6 | US FAERS | |
| 208 | Retching | FAERS: 6 | US FAERS | |
| 209 | Septic Shock | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 210 | Sneezing | FAERS: 6 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 211 | Therapeutic product ineffective | FAERS: 6 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 212 | Tongue blistering | FAERS: 6 | US FAERS | |
| 213 | Unresponsive to stimuli | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 214 | nervous system disorder | FAERS: 6 | SIDER US FAERS | |
| 215 | Ageusia | FAERS: 5 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 216 | Anal abscess | FAERS: 5 | US FAERS | |
| 217 | Angina Pectoris | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 218 | Arthritis | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 219 | Blood iron decreased | FAERS: 5 | US FAERS | |
| 220 | Blood phosphorus decreased | FAERS: 5 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 221 | Blood thyroid stimulating hormone increased | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 222 | Cardiac Arrest | FAERS: 5 | US FAERS | |
| 223 | Depressed mood | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 224 | Dermatitis acneiform | FAERS: 5 | US FAERS | |
| 225 | Disease complication | FAERS: 5 | US FAERS | |
| 226 | Drug ineffective for unapproved indication | FAERS: 5 | US FAERS | |
| 227 | Ear discomfort | FAERS: 5 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 228 | Febrile Neutropenia | FAERS: 5 | US FAERS | |
| 229 | Gastric ulcer | FAERS: 5 | US FAERS | |
| 230 | Incorrect dose administered | FAERS: 5 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 231 | Liver carcinoma ruptured | FAERS: 5 | US FAERS | |
| 232 | Palmar erythema | FAERS: 5 | US FAERS | |
| 233 | Product packaging quantity issue | FAERS: 5 | US FAERS | |
| 234 | Protein urine present | FAERS: 5 | SIDER US FAERS | |
| 235 | Retroperitoneal lymphadenopathy | FAERS: 5 | US FAERS | |
| 236 | Skin irritation | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 237 | Systemic Inflammatory Response Syndrome | FAERS: 5 | US FAERS | |
| 238 | Tongue discomfort | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 239 | Tumour haemorrhage | FAERS: 5 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 240 | Aphasia | FAERS: 4 | US FAERS | |
| 241 | Asthma | FAERS: 4 | US FAERS | |
| 242 | Blindness | FAERS: 4 | US FAERS | |
| 243 | Blood bilirubin abnormal | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 244 | Central nervous system lesion | FAERS: 4 | US FAERS | |
| 245 | Colitis | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 246 | Dermatitis | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 247 | Eczema | FAERS: 4 | US FAERS | |
| 248 | Electrolyte imbalance | FAERS: 4 | US FAERS | |
| 249 | Emergency Care | FAERS: 4 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 250 | Fibrin D dimer increased | FAERS: 4 | US FAERS | |
| 251 | Gastrointestinal carcinoma | FAERS: 4 | US FAERS | |
| 252 | Gastrointestinal perforation | FAERS: 4 | SIDER US FAERS | |
| 253 | Glossitis | FAERS: 4 | US FAERS | |
| 254 | Incorrect drug administration duration | FAERS: 4 | US FAERS | |
| 255 | Increased upper airway secretion | FAERS: 4 | US FAERS | |
| 256 | Intestinal Fistula | FAERS: 4 | US FAERS | |
| 257 | Leukopenia | FAERS: 4 | SIDER US FAERS | |
| 258 | Malnutrition | FAERS: 4 | SIDER US FAERS | |
| 259 | Metastases to abdominal cavity | FAERS: 4 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 260 | Nervousness | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 261 | Obstruction | FAERS: 4 | US FAERS | |
| 262 | Oral fungal infection | FAERS: 4 | US FAERS | |
| 263 | Prerenal failure | FAERS: 4 | US FAERS | |
| 264 | Rectal discharge | FAERS: 4 | US FAERS | |
| 265 | Rectosigmoid cancer | FAERS: 4 | US FAERS | |
| 266 | Renal pain | FAERS: 4 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 267 | Respiratory Failure | FAERS: 4 | US FAERS | |
| 268 | Restlessness | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 269 | Retinal Detachment | FAERS: 4 | US FAERS | |
| 270 | Terminal state | FAERS: 4 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 271 | Throat irritation | FAERS: 4 | US FAERS | |
| 272 | treatment failure | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 273 | Acute myocardial infarction | FAERS: 3 | US FAERS | |
| 274 | Anal Fissure | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 275 | Anal Fistula | FAERS: 3 | US FAERS | |
| 276 | Angioedema | FAERS: 3 | US FAERS | |
| 277 | Angiotensin converting enzyme increased | FAERS: 3 | US FAERS | |
| 278 | Bowel movement irregularity | FAERS: 3 | US FAERS | |
| 279 | Carbohydrate antigen 19-9 increased | FAERS: 3 | US FAERS | |
| 280 | Cholecystitis infective | FAERS: 3 | US FAERS | |
| 281 | Clostridium difficile infection | FAERS: 3 | US FAERS | |
| 282 | Deafness | FAERS: 3 | US FAERS | |
| 283 | Dementia | FAERS: 3 | US FAERS | |
| 284 | Device occlusion | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 285 | Diplopia | FAERS: 3 | US FAERS | |
| 286 | Dysarthria | FAERS: 3 | US FAERS | |
| 287 | Ejection Fraction Decreased | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 288 | Enterocolitis | FAERS: 3 | US FAERS | |
| 289 | Eructation | FAERS: 3 | US FAERS | |
| 290 | Exfoliative rash | FAERS: 3 | SIDER US FAERS | |
| 291 | Eye pain | FAERS: 3 | US FAERS | |
| 292 | Failure to Thrive | FAERS: 3 | US FAERS | |
| 293 | Feeling of body temperature change | FAERS: 3 | US FAERS | |
| 294 | Flank Pain | FAERS: 3 | US FAERS | |
| 295 | Flushing | FAERS: 3 | US FAERS | |
| 296 | Gastrointestinal infection | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 297 | Genital rash | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 298 | Gout | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 299 | Hyperphagia | FAERS: 3 | US FAERS | |
| 300 | Hypertransaminasaemia | FAERS: 3 | US FAERS | |
| 301 | Inappropriate schedule of product administration | FAERS: 3 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 302 | Incoherent | FAERS: 3 | US FAERS | |
| 303 | Increased tendency to bruise | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 304 | Intra-abdominal fluid collection | FAERS: 3 | US FAERS | |
| 305 | Joint injury | FAERS: 3 | US FAERS | |
| 306 | Laceration | FAERS: 3 | US FAERS | |
| 307 | Lymphangiosis carcinomatosa | FAERS: 3 | US FAERS | |
| 308 | Mediastinal mass | FAERS: 3 | US FAERS | |
| 309 | Medication Error | FAERS: 3 | US FAERS | |
| 310 | Metastatic Neoplasm | FAERS: 3 | US FAERS | |
| 311 | Middle insomnia | FAERS: 3 | US FAERS | |
| 312 | Muscle Fatigue | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 313 | Onychoclasis | FAERS: 3 | US FAERS | |
| 314 | Osteonecrosis of Jaw | FAERS: 3 | US FAERS | |
| 315 | Overdose | FAERS: 3 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 316 | Pericardial effusion | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 317 | Photophobia | FAERS: 3 | US FAERS | |
| 318 | Pleurisy | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 319 | Pneumoperitoneum | FAERS: 3 | US FAERS | |
| 320 | Post-traumatic pain | FAERS: 3 | US FAERS | |
| 321 | Product use complaint | FAERS: 3 | US FAERS | |
| 322 | Quality of life decreased | FAERS: 3 | US FAERS | |
| 323 | Respiratory tract congestion | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 324 | Retinal Vein Occlusion | FAERS: 3 | US FAERS | |
| 325 | Rhabdomyolysis | FAERS: 3 | US FAERS | |
| 326 | Sciatica | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 327 | Sinus headache | FAERS: 3 | US FAERS | |
| 328 | Sinusitis | FAERS: 3 | US FAERS | |
| 329 | Skin Papilloma | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 330 | Skin tightness | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 331 | Sudden death | FAERS: 3 | US FAERS | |
| 332 | Therapy non-responder | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 333 | Thirst | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 334 | Ulcer | FAERS: 3 | US FAERS | |
| 335 | Uveitis | FAERS: 3 | US FAERS | |
| 336 | VIIth nerve paralysis | FAERS: 3 | US FAERS | |
| 337 | Wheezing | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 338 | Wound Complication | FAERS: 3 | US FAERS | |
| 339 | Wrong technique in drug usage process | FAERS: 3 | US FAERS | |
| 340 | furuncle | FAERS: 3 | US FAERS | |
| 341 | Abdominal Abscess | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 342 | Abdominal mass | FAERS: 2 | US FAERS | |
| 343 | Abdominal rigidity | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 344 | Abscess | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 345 | Acute prerenal failure | FAERS: 2 | US FAERS | |
| 346 | Agitation | FAERS: 2 | US FAERS | |
| 347 | Amylase increased | FAERS: 2 | SIDER US FAERS | |
| 348 | Anal Ulcer | FAERS: 2 | US FAERS | |
| 349 | Anal inflammation | FAERS: 2 | US FAERS | |
| 350 | Anuria | FAERS: 2 | US FAERS | |
| 351 | Aphthous Stomatitis | FAERS: 2 | US FAERS | |
| 352 | Arthropathy | FAERS: 2 | US FAERS | |
| 353 | Aspartate aminotransferase abnormal | FAERS: 2 | US FAERS | |
| 354 | Asthenopia | FAERS: 2 | US FAERS | |
| 355 | Bacterial sepsis | FAERS: 2 | US FAERS | |
| 356 | Blood bilirubin unconjugated increased | FAERS: 2 | US FAERS | |
| 357 | Brain natriuretic peptide increased | FAERS: 2 | US FAERS | |
| 358 | Carcinoembryonic antigen decreased | FAERS: 2 | US FAERS | |
| 359 | Cardiac dysfunction | FAERS: 2 | US FAERS | |
| 360 | Cardiomegaly | FAERS: 2 | US FAERS | |
| 361 | Catheter placement | FAERS: 2 | US FAERS | |
| 362 | Cellulitis | FAERS: 2 | US FAERS | |
| 363 | Choking sensation | FAERS: 2 | US FAERS | |
| 364 | Choking | FAERS: 2 | US FAERS | |
| 365 | Clostridium difficile colitis | FAERS: 2 | US FAERS | |
| 366 | Critical Illness | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 367 | Cytopenia | FAERS: 2 | US FAERS | |
| 368 | Device related infection | FAERS: 2 | US FAERS | |
| 369 | Drug administration error | FAERS: 2 | US FAERS | |
| 370 | Dyschezia | FAERS: 2 | US FAERS | |
| 371 | Embolism | FAERS: 2 | US FAERS | |
| 372 | Encephalitis | FAERS: 2 | US FAERS | |
| 373 | Escherichia urinary tract infection | FAERS: 2 | US FAERS | |
| 374 | Exophthalmos | FAERS: 2 | US FAERS | |
| 375 | Eye inflammation | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 376 | Facial Pain | FAERS: 2 | US FAERS | |
| 377 | Feeling jittery | FAERS: 2 | US FAERS | |
| 378 | Folliculitis | FAERS: 2 | US FAERS | |
| 379 | Foreign body in respiratory tract | FAERS: 2 | US FAERS | |
| 380 | Fracture | FAERS: 2 | US FAERS | |
| 381 | Fungal pharyngitis | FAERS: 2 | US FAERS | |
| 382 | General physical condition abnormal | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 383 | Genital erosion | FAERS: 2 | US FAERS | |
| 384 | Gingival Recession | FAERS: 2 | US FAERS | |
| 385 | Gingivitis | FAERS: 2 | US FAERS | |
| 386 | Grip strength decreased | FAERS: 2 | US FAERS | |
| 387 | Hemiparesis | FAERS: 2 | US FAERS | |
| 388 | Hemiplegia | FAERS: 2 | US FAERS | |
| 389 | Herpes dermatitis | FAERS: 2 | US FAERS | |
| 390 | Hyperchlorhydria | FAERS: 2 | US FAERS | |
| 391 | Hypoxia | FAERS: 2 | US FAERS | |
| 392 | Icterus index increased | FAERS: 2 | US FAERS | |
| 393 | Impaired self-care | FAERS: 2 | US FAERS | |
| 394 | Impaired work ability | FAERS: 2 | US FAERS | |
| 395 | Incorrect product administration duration | FAERS: 2 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 396 | Infected neoplasm | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 397 | Infrequent bowel movements | FAERS: 2 | US FAERS | |
| 398 | Interventional procedure | FAERS: 2 | US FAERS | |
| 399 | Intestinal metastasis | FAERS: 2 | US FAERS | |
| 400 | Joint Range of Motion Decreased | FAERS: 2 | US FAERS | |
| 401 | Joint stiffness | FAERS: 2 | US FAERS | |
| 402 | Lip swelling | FAERS: 2 | US FAERS | |
| 403 | Liver Abscess | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 404 | Lower respiratory tract infection | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 405 | Lymphangitis | FAERS: 2 | US FAERS | |
| 406 | Medication residue present | FAERS: 2 | US FAERS | |
| 407 | Metastases to abdominal wall | FAERS: 2 | US FAERS | |
| 408 | Metastases to pelvis | FAERS: 2 | US FAERS | |
| 409 | Mucosal toxicity | FAERS: 2 | US FAERS | |
| 410 | Multiple allergies | FAERS: 2 | US FAERS | |
| 411 | Muscle tightness | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 412 | N-terminal prohormone brain natriuretic peptide increased | FAERS: 2 | US FAERS | |
| 413 | Nephrolithiasis | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 414 | No adverse event | FAERS: 2 | US FAERS | |
| 415 | Nodule | FAERS: 2 | US FAERS | |
| 416 | Oliguria | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 417 | Oncologic complication | FAERS: 2 | US FAERS | |
| 418 | Onycholysis | FAERS: 2 | US FAERS | |
| 419 | Oral mucosal erythema | FAERS: 2 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 420 | Osteomyelitis | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 421 | Pallor | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 422 | Pancytopenia | FAERS: 2 | US FAERS | |
| 423 | Paranasal sinus discomfort | FAERS: 2 | US FAERS | |
| 424 | Paranasal sinus hypersecretion | FAERS: 2 | US FAERS | |
| 425 | Pelvic Pain | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 426 | Perianal erythema | FAERS: 2 | US FAERS | |
| 427 | Pneumatosis intestinalis | FAERS: 2 | US FAERS | |
| 428 | Pneumothorax | FAERS: 2 | US FAERS | |
| 429 | Poisoning | FAERS: 2 | US FAERS | |
| 430 | Polyuria | FAERS: 2 | US FAERS | |
| 431 | Poor peripheral circulation | FAERS: 2 | US FAERS | |
| 432 | Post procedural complication | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 433 | Postoperative wound complication | FAERS: 2 | US FAERS | |
| 434 | Presyncope | FAERS: 2 | US FAERS | |
| 435 | Pulmonary pain | FAERS: 2 | US FAERS | |
| 436 | Purpura | FAERS: 2 | US FAERS | |
| 437 | Rectal abscess | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 438 | Rectosigmoid cancer metastatic | FAERS: 2 | US FAERS | |
| 439 | Respiratory arrest | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 440 | Respiratory distress | FAERS: 2 | US FAERS | |
| 441 | Rheumatoid Arthritis | FAERS: 2 | US FAERS | |
| 442 | Rhinalgia | FAERS: 2 | US FAERS | |
| 443 | Rhinitis | FAERS: 2 | US FAERS | |
| 444 | Secretion discharge | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 445 | Skin hypertrophy | FAERS: 2 | US FAERS | |
| 446 | Slow speech | FAERS: 2 | US FAERS | |
| 447 | Sluggishness | FAERS: 2 | US FAERS | |
| 448 | Splenomegaly | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 449 | Squamous cell carcinoma of skin | FAERS: 2 | US FAERS | |
| 450 | Stoma complication | FAERS: 2 | US FAERS | |
| 451 | Stress | FAERS: 2 | US FAERS | |
| 452 | Suspected counterfeit product | FAERS: 2 | US FAERS | |
| 453 | Systolic hypertension | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 454 | Thermal burn | FAERS: 2 | US FAERS | |
| 455 | Thermohyperaesthesia | FAERS: 2 | US FAERS | |
| 456 | Thoracic cavity drainage | FAERS: 2 | US FAERS | |
| 457 | Tongue fungal infection | FAERS: 2 | US FAERS | |
| 458 | Toothache | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 459 | Trousseau's syndrome | FAERS: 2 | US FAERS | |
| 460 | Upper-airway cough syndrome | FAERS: 2 | US FAERS | |
| 461 | Urinary Tract Pain | FAERS: 2 | US FAERS | |
| 462 | Urinary tract obstruction | FAERS: 2 | US FAERS | |
| 463 | Vaginal lesion | FAERS: 2 | US FAERS | |
| 464 | Vasculitis | FAERS: 2 | US FAERS | |
| 465 | Venous Thrombosis | FAERS: 2 | US FAERS | |
| 466 | Vertigo | FAERS: 2 | US FAERS | |
| 467 | Wheelchair user | FAERS: 2 | US FAERS | |
| 468 | Wound Infection | FAERS: 2 | US FAERS | |
| 469 | colonoscopy | FAERS: 2 | US FAERS | |
| 470 | Abdominal adhesions | FAERS: 1 | US FAERS | |
| 471 | Accidental exposure to product | FAERS: 1 | US FAERS | |
| 472 | Accidental overdose | FAERS: 1 | US FAERS | |
| 473 | Activated partial thromboplastin time abnormal | FAERS: 1 | US FAERS | |
| 474 | Acute respiratory failure | FAERS: 1 | US FAERS | |
| 475 | Agranulocytosis | FAERS: 1 | US FAERS | |
| 476 | Alanine aminotransferase abnormal | FAERS: 1 | US FAERS | |
| 477 | Anal fungal infection | FAERS: 1 | US FAERS | |
| 478 | Angioplasty | FAERS: 1 | US FAERS | |
| 479 | Angular cheilitis | FAERS: 1 | US FAERS | |
| 480 | Anhidrosis | FAERS: 1 | US FAERS | |
| 481 | Ankle Fracture | FAERS: 1 | US FAERS | |
| 482 | Anorectal swelling | FAERS: 1 | US FAERS | |
| 483 | Anticoagulant therapy | FAERS: 1 | US FAERS | |
| 484 | Anticoagulation drug level above therapeutic | FAERS: 1 | US FAERS | |
| 485 | Anticonvulsant drug level above therapeutic | FAERS: 1 | US FAERS | |
| 486 | Arteriovenous fistula thrombosis | FAERS: 1 | US FAERS | |
| 487 | Arteritis | FAERS: 1 | US FAERS | |
| 488 | Arthropod bite | FAERS: 1 | US FAERS | |
| 489 | Asterixis | FAERS: 1 | US FAERS | |
| 490 | Ataxia | FAERS: 1 | US FAERS | |
| 491 | Back disorder | FAERS: 1 | US FAERS | |
| 492 | Bacterial test positive | FAERS: 1 | US FAERS | |
| 493 | Benign neoplasm of adrenal gland | FAERS: 1 | US FAERS | |
| 494 | Benign neoplasm of skin | FAERS: 1 | US FAERS | |
| 495 | Bile Duct Stenosis | FAERS: 1 | US FAERS | |
| 496 | Biliary Colic | FAERS: 1 | US FAERS | |
| 497 | Biliary tract infection | FAERS: 1 | US FAERS | |
| 498 | Bilirubin conjugated increased | FAERS: 1 | US FAERS | |
| 499 | Bilirubin urine present | FAERS: 1 | US FAERS | |
| 500 | Bladder spasm | FAERS: 1 | US FAERS | |
| 501 | Blood alkaline phosphatase abnormal | FAERS: 1 | US FAERS | |
| 502 | Blood creatine increased | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 503 | Blood electrolytes abnormal | FAERS: 1 | US FAERS | |
| 504 | Blood electrolytes decreased | FAERS: 1 | US FAERS | |
| 505 | Blood lactate dehydrogenase abnormal | FAERS: 1 | US FAERS | |
| 506 | Blood potassium abnormal | FAERS: 1 | US FAERS | |
| 507 | Blood pressure inadequately controlled | FAERS: 1 | US FAERS | |
| 508 | Blood thyroid stimulating hormone abnormal | FAERS: 1 | US FAERS | |
| 509 | Blood thyroid stimulating hormone decreased | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 510 | Blood triglycerides increased | FAERS: 1 | US FAERS | |
| 511 | Bone density increased | FAERS: 1 | US FAERS | |
| 512 | Breakthrough Pain | FAERS: 1 | US FAERS | |
| 513 | Breast discomfort | FAERS: 1 | US FAERS | |
| 514 | Breast tenderness | FAERS: 1 | US FAERS | |
| 515 | Bronchial Hyperreactivity | FAERS: 1 | US FAERS | |
| 516 | Buccal mucosal roughening | FAERS: 1 | US FAERS | |
| 517 | C-reactive protein abnormal | FAERS: 1 | US FAERS | |
| 518 | Calcinosis | FAERS: 1 | US FAERS | |
| 519 | Carbon dioxide increased | FAERS: 1 | US FAERS | |
| 520 | Cardiac enzymes increased | FAERS: 1 | US FAERS | |
| 521 | Cardiac ventricular disorder | FAERS: 1 | US FAERS | |
| 522 | Cataract operation | FAERS: 1 | US FAERS | |
| 523 | Catarrh | FAERS: 1 | US FAERS | |
| 524 | Catheter site pain | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 525 | Cell Death | FAERS: 1 | US FAERS | |
| 526 | Cell marker decreased | FAERS: 1 | US FAERS | |
| 527 | Cerebral atrophy | FAERS: 1 | US FAERS | |
| 528 | Cerebral calcification | FAERS: 1 | US FAERS | |
| 529 | Child-Pugh-Turcotte score increased | FAERS: 1 | US FAERS | |
| 530 | Cholelithotomy | FAERS: 1 | US FAERS | |
| 531 | Cholestatic pruritus | FAERS: 1 | US FAERS | |
| 532 | Coagulation test abnormal | FAERS: 1 | US FAERS | |
| 533 | Coating in mouth | FAERS: 1 | US FAERS | |
| 534 | Colectomy | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 535 | Colorectal cancer recurrent | FAERS: 1 | US FAERS | |
| 536 | Contraindicated drug administered | FAERS: 1 | US FAERS | |
| 537 | Coombs test positive | FAERS: 1 | US FAERS | |
| 538 | Corneal erosion | FAERS: 1 | US FAERS | |
| 539 | Coronary Artery Disease | FAERS: 1 | US FAERS | |
| 540 | Crying | FAERS: 1 | US FAERS | |
| 541 | Cyanosis | FAERS: 1 | US FAERS | |
| 542 | Decreased immune responsiveness | FAERS: 1 | US FAERS | |
| 543 | Dental caries | FAERS: 1 | US FAERS | |
| 544 | Dermo-hypodermitis | FAERS: 1 | US FAERS | |
| 545 | Device related sepsis | FAERS: 1 | US FAERS | |
| 546 | Diabetic Foot | FAERS: 1 | US FAERS | |
| 547 | Diaphragmatic Hernia | FAERS: 1 | US FAERS | |
| 548 | Dieulafoy's vascular malformation | FAERS: 1 | US FAERS | |
| 549 | Drain placement | FAERS: 1 | US FAERS | |
| 550 | Drug administered to patient of inappropriate age | FAERS: 1 | US FAERS | |
| 551 | Drug dispensing error | FAERS: 1 | US FAERS | |
| 552 | Drug prescribing error | FAERS: 1 | US FAERS | |
| 553 | Drug resistance | FAERS: 1 | US FAERS | |
| 554 | Duodenal Ulcer | FAERS: 1 | US FAERS | |
| 555 | Dysacusis | FAERS: 1 | US FAERS | |
| 556 | Dyslalia | FAERS: 1 | US FAERS | |
| 557 | Dystonia | FAERS: 1 | US FAERS | |
| 558 | Ecchymosis | FAERS: 1 | US FAERS | |
| 559 | Eccrine squamous syringometaplasia | FAERS: 1 | US FAERS | |
| 560 | Endoscopic Retrograde Cholangiopancreatography | FAERS: 1 | US FAERS | |
| 561 | Enterococcal sepsis | FAERS: 1 | US FAERS | |
| 562 | Enterocolitis fungal | FAERS: 1 | US FAERS | |
| 563 | Enterocutaneous Fistula | FAERS: 1 | US FAERS | |
| 564 | Enuresis | FAERS: 1 | US FAERS | |
| 565 | Eosinophilia | FAERS: 1 | US FAERS | |
| 566 | Epidermolysis Bullosa | FAERS: 1 | US FAERS | |
| 567 | Epigastric discomfort | FAERS: 1 | US FAERS | |
| 568 | Erectile dysfunction | FAERS: 1 | US FAERS | |
| 569 | Expired drug administered | FAERS: 1 | US FAERS | |
| 570 | Exposed bone in jaw | FAERS: 1 | US FAERS | |
| 571 | Exposure via partner | FAERS: 1 | US FAERS | |
| 572 | Expulsion of medication | FAERS: 1 | US FAERS | |
| 573 | Extra dose administered | FAERS: 1 | US FAERS | |
| 574 | Eye Infection | FAERS: 1 | US FAERS | |
| 575 | Facial Paresis | FAERS: 1 | US FAERS | |
| 576 | Facial paralysis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 577 | Fat intolerance | FAERS: 1 | US FAERS | |
| 578 | Fear of falling | FAERS: 1 | US FAERS | |
| 579 | Food aversion | FAERS: 1 | US FAERS | |
| 580 | Formication | FAERS: 1 | US FAERS | |
| 581 | Full blood count decreased | FAERS: 1 | US FAERS | |
| 582 | Gait deviation | FAERS: 1 | US FAERS | |
| 583 | Gamma-glutamyltransferase abnormal | FAERS: 1 | US FAERS | |
| 584 | Gangrene | FAERS: 1 | US FAERS | |
| 585 | Gastrectomy | FAERS: 1 | US FAERS | |
| 586 | Gastric Dilatation | FAERS: 1 | US FAERS | |
| 587 | Gastric infection | FAERS: 1 | US FAERS | |
| 588 | Gastritis | FAERS: 1 | US FAERS | |
| 589 | Gastrointestinal inflammation | FAERS: 1 | US FAERS | |
| 590 | Gastrointestinal obstruction | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 591 | Gastrointestinal sounds abnormal | FAERS: 1 | US FAERS | |
| 592 | Gastrointestinal stoma complication | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 593 | Gastrointestinal stoma output decreased | FAERS: 1 | US FAERS | |
| 594 | Gastrointestinal ulcer perforation | FAERS: 1 | US FAERS | |
| 595 | Gastrointestinal ulcer | FAERS: 1 | US FAERS | |
| 596 | Gastrostomy | FAERS: 1 | US FAERS | |
| 597 | Gene Mutation | FAERS: 1 | US FAERS | |
| 598 | General physical condition decreased | FAERS: 1 | US FAERS | |
| 599 | General symptom | FAERS: 1 | US FAERS | |
| 600 | Genital Herpes | FAERS: 1 | US FAERS | |
| 601 | Genital abscess | FAERS: 1 | US FAERS | |
| 602 | Genital discomfort | FAERS: 1 | US FAERS | |
| 603 | Gingival blister | FAERS: 1 | US FAERS | |
| 604 | Gingival discomfort | FAERS: 1 | US FAERS | |
| 605 | Glaucoma | FAERS: 1 | US FAERS | |
| 606 | Groin infection | FAERS: 1 | US FAERS | |
| 607 | Hallucinations, mixed | FAERS: 1 | US FAERS | |
| 608 | Head discomfort | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 609 | Hepatic necrosis | FAERS: 1 | US FAERS | |
| 610 | Hernia pain | FAERS: 1 | US FAERS | |
| 611 | Hernia | FAERS: 1 | US FAERS | |
| 612 | Hilar lymphadenopathy | FAERS: 1 | US FAERS | |
| 613 | Histiocytosis haematophagic | FAERS: 1 | US FAERS | |
| 614 | Hunger | FAERS: 1 | US FAERS | |
| 615 | Hypercreatinaemia | FAERS: 1 | US FAERS | |
| 616 | Hypercreatininaemia | FAERS: 1 | US FAERS | |
| 617 | Hyperlipasaemia | FAERS: 1 | US FAERS | |
| 618 | Hyperphosphaturia | FAERS: 1 | US FAERS | |
| 619 | Hyperpyrexia | FAERS: 1 | US FAERS | |
| 620 | Hypertensive Encephalopathy | FAERS: 1 | US FAERS | |
| 621 | Hypertensive cardiomyopathy | FAERS: 1 | US FAERS | |
| 622 | Hypertensive emergency | FAERS: 1 | US FAERS | |
| 623 | Hypertrophic Cardiomyopathy | FAERS: 1 | US FAERS | |
| 624 | Hypogeusia | FAERS: 1 | US FAERS | |
| 625 | Ileal Stenosis | FAERS: 1 | US FAERS | |
| 626 | Immune thrombocytopenic purpura | FAERS: 1 | US FAERS | |
| 627 | Impaired driving ability | FAERS: 1 | US FAERS | |
| 628 | Impaired quality of life | FAERS: 1 | US FAERS | |
| 629 | Impatience | FAERS: 1 | US FAERS | |
| 630 | Inability to afford medication | FAERS: 1 | US FAERS | |
| 631 | Inappropriate Prescribing | FAERS: 1 | US FAERS | |
| 632 | Incision site abscess | FAERS: 1 | US FAERS | |
| 633 | Incision site vesicles | FAERS: 1 | US FAERS | |
| 634 | Incontinence | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 635 | Incorrect route of drug administration | FAERS: 1 | US FAERS | |
| 636 | Incorrect route of product administration | FAERS: 1 | US FAERS | |
| 637 | Induration | FAERS: 1 | US FAERS | |
| 638 | Infarction | FAERS: 1 | SIDER US FAERS | |
| 639 | Inflammatory marker increased | FAERS: 1 | US FAERS | |
| 640 | Initial insomnia | FAERS: 1 | US FAERS | |
| 641 | Intentional dose omission | FAERS: 1 | US FAERS | |
| 642 | Intercepted drug dispensing error | FAERS: 1 | US FAERS | |
| 643 | Intermittent Claudication | FAERS: 1 | US FAERS | |
| 644 | Internal injury | FAERS: 1 | US FAERS | |
| 645 | Intestinal fibrosis | FAERS: 1 | US FAERS | |
| 646 | Intestinal resection | FAERS: 1 | US FAERS | |
| 647 | Intracranial Aneurysm | FAERS: 1 | US FAERS | |
| 648 | Karnofsky scale worsened | FAERS: 1 | US FAERS | |
| 649 | Keratitis | FAERS: 1 | US FAERS | |
| 650 | Labile blood pressure | FAERS: 1 | US FAERS | |
| 651 | Laparotomy | FAERS: 1 | US FAERS | |
| 652 | Laryngeal nerve dysfunction | FAERS: 1 | US FAERS | |
| 653 | Laryngitis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 654 | Laziness | FAERS: 1 | US FAERS | |
| 655 | Leukocytosis | FAERS: 1 | US FAERS | |
| 656 | Limb mass | FAERS: 1 | US FAERS | |
| 657 | Liposarcoma metastatic | FAERS: 1 | US FAERS | |
| 658 | Loose tooth | FAERS: 1 | US FAERS | |
| 659 | Lower gastrointestinal perforation | FAERS: 1 | US FAERS | |
| 660 | Lung consolidation | FAERS: 1 | US FAERS | |
| 661 | Lymphoma | FAERS: 1 | US FAERS | |
| 662 | Lymphopenia | FAERS: 1 | SIDER US FAERS | |
| 663 | Malignant ascites | FAERS: 1 | US FAERS | |
| 664 | Mallory-Weiss Syndrome | FAERS: 1 | US FAERS | |
| 665 | Marasmus | FAERS: 1 | US FAERS | |
| 666 | Mastication disorder | FAERS: 1 | US FAERS | |
| 667 | Mesenteric Panniculitis | FAERS: 1 | US FAERS | |
| 668 | Mesenteric neoplasm | FAERS: 1 | US FAERS | |
| 669 | Metabolic acidosis | FAERS: 1 | US FAERS | |
| 670 | Metamorphopsia | FAERS: 1 | US FAERS | |
| 671 | Micturition frequency decreased | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 672 | Miliaria | FAERS: 1 | US FAERS | |
| 673 | Monoparesis | FAERS: 1 | US FAERS | |
| 674 | Mouth swelling | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 675 | Mucosal Infection | FAERS: 1 | US FAERS | |
| 676 | Muscle Rigidity | FAERS: 1 | US FAERS | |
| 677 | Muscle strain | FAERS: 1 | US FAERS | |
| 678 | Nephritic syndrome | FAERS: 1 | US FAERS | |
| 679 | Nephritis | FAERS: 1 | US FAERS | |
| 680 | Neutrophil count abnormal | FAERS: 1 | US FAERS | |
| 681 | Noninfective gingivitis | FAERS: 1 | US FAERS | |
| 682 | Nutritional condition abnormal | FAERS: 1 | US FAERS | |
| 683 | Occult blood positive | FAERS: 1 | US FAERS | |
| 684 | Ocular Toxicity | FAERS: 1 | US FAERS | |
| 685 | Oligodipsia | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 686 | Onychomycosis | FAERS: 1 | US FAERS | |
| 687 | Oral infection | FAERS: 1 | US FAERS | |
| 688 | Oral mucosal eruption | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 689 | Oropharyngeal blistering | FAERS: 1 | US FAERS | |
| 690 | Orthostatic hypertension | FAERS: 1 | US FAERS | |
| 691 | Osteosarcoma | FAERS: 1 | US FAERS | |
| 692 | Pancreatectomy | FAERS: 1 | US FAERS | |
| 693 | Panniculitis | FAERS: 1 | US FAERS | |
| 694 | Paraneoplastic neurological syndrome | FAERS: 1 | US FAERS | |
| 695 | Paratracheal lymphadenopathy | FAERS: 1 | US FAERS | |
| 696 | Paravenous drug administration | FAERS: 1 | US FAERS | |
| 697 | Patient dissatisfaction with treatment | FAERS: 1 | US FAERS | |
| 698 | Penile necrosis | FAERS: 1 | US FAERS | |
| 699 | Petechiae | FAERS: 1 | US FAERS | |
| 700 | Pharyngitis | FAERS: 1 | US FAERS | |
| 701 | Phlebitis | FAERS: 1 | US FAERS | |
| 702 | Physical deconditioning | FAERS: 1 | US FAERS | |
| 703 | Platelet count abnormal | FAERS: 1 | US FAERS | |
| 704 | Pleuritic pain | FAERS: 1 | US FAERS | |
| 705 | Pleurodesis | FAERS: 1 | US FAERS | |
| 706 | Polyarthritis | FAERS: 1 | US FAERS | |
| 707 | Polyneuropathy | FAERS: 1 | US FAERS | |
| 708 | Portal Vein Thrombosis | FAERS: 1 | US FAERS | |
| 709 | Post procedural discharge | FAERS: 1 | US FAERS | |
| 710 | Postrenal failure | FAERS: 1 | US FAERS | |
| 711 | Pouchitis | FAERS: 1 | US FAERS | |
| 712 | Prescribed overdose | FAERS: 1 | US FAERS | |
| 713 | Prescribed underdose | FAERS: 1 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 714 | Procedural failure | FAERS: 1 | US FAERS | |
| 715 | Proctitis | FAERS: 1 | US FAERS | |
| 716 | Product administration error | FAERS: 1 | US FAERS | |
| 717 | Product container issue | FAERS: 1 | US FAERS | |
| 718 | Product container seal issue | FAERS: 1 | US FAERS | |
| 719 | Product difficult to swallow | FAERS: 1 | US FAERS | |
| 720 | Product dispensing error | FAERS: 1 | US FAERS | |
| 721 | Product label confusion | FAERS: 1 | US FAERS | |
| 722 | Product label issue | FAERS: 1 | US FAERS | |
| 723 | Product quality issue | FAERS: 1 | US FAERS | |
| 724 | Product size issue | FAERS: 1 | US FAERS | |
| 725 | Product supply issue | FAERS: 1 | US FAERS | |
| 726 | Product tampering | FAERS: 1 | US FAERS | |
| 727 | Prosopagnosia | FAERS: 1 | US FAERS | |
| 728 | Protein Deficiency | FAERS: 1 | US FAERS | |
| 729 | Protein total abnormal | FAERS: 1 | US FAERS | |
| 730 | Protein total decreased | FAERS: 1 | US FAERS | |
| 731 | Prothrombin level decreased | FAERS: 1 | US FAERS | |
| 732 | Prothrombin time abnormal | FAERS: 1 | US FAERS | |
| 733 | Pruritus allergic | FAERS: 1 | US FAERS | |
| 734 | Pseudocirrhosis | FAERS: 1 | US FAERS | |
| 735 | Psoriasis | FAERS: 1 | US FAERS | |
| 736 | Pubic pain | FAERS: 1 | US FAERS | |
| 737 | Pulmonary Fibrosis | FAERS: 1 | US FAERS | |
| 738 | Pyelonephritis | FAERS: 1 | US FAERS | |
| 739 | Radiation injury | FAERS: 1 | US FAERS | |
| 740 | Radiation skin injury | FAERS: 1 | US FAERS | |
| 741 | Radiotherapy to liver | FAERS: 1 | US FAERS | |
| 742 | Rales | FAERS: 1 | US FAERS | |
| 743 | Rectal injury | FAERS: 1 | US FAERS | |
| 744 | Red blood cell hypochromic morphology present | FAERS: 1 | US FAERS | |
| 745 | Refractory cancer | FAERS: 1 | US FAERS | |
| 746 | Regurgitation | FAERS: 1 | US FAERS | |
| 747 | Rehabilitation therapy | FAERS: 1 | US FAERS | |
| 748 | Renal cyst | FAERS: 1 | US FAERS | |
| 749 | Renal tubular disorder | FAERS: 1 | US FAERS | |
| 750 | Renal tubular necrosis | FAERS: 1 | US FAERS | |
| 751 | Restless Legs Syndrome | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 752 | Rheumatic disorder | FAERS: 1 | US FAERS | |
| 753 | Scab | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 754 | Scrotal Infection | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 755 | Scrotal erythema | FAERS: 1 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 756 | Shock | FAERS: 1 | US FAERS | |
| 757 | Shunt occlusion | FAERS: 1 | US FAERS | |
| 758 | Sinus Tachycardia | FAERS: 1 | US FAERS | |
| 759 | Skin Erosion | FAERS: 1 | US FAERS | |
| 760 | Skin Wrinkling | FAERS: 1 | US FAERS | |
| 761 | Skin discomfort | FAERS: 1 | US FAERS | |
| 762 | Skin necrosis | FAERS: 1 | US FAERS | |
| 763 | Skin texture abnormal | FAERS: 1 | US FAERS | |
| 764 | Sleep Talking | FAERS: 1 | US FAERS | |
| 765 | Slow response to stimuli | FAERS: 1 | US FAERS | |
| 766 | Small intestine carcinoma | FAERS: 1 | US FAERS | |
| 767 | Splenectomy | FAERS: 1 | US FAERS | |
| 768 | Stoma site abscess | FAERS: 1 | US FAERS | |
| 769 | Stoma site reaction | FAERS: 1 | US FAERS | |
| 770 | Stoma site ulcer | FAERS: 1 | US FAERS | |
| 771 | Strangulated hernia | FAERS: 1 | US FAERS | |
| 772 | Subcutaneous Abscess | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 773 | Suicide attempt | FAERS: 1 | US FAERS | |
| 774 | Tension | FAERS: 1 | US FAERS | |
| 775 | Testis discomfort | FAERS: 1 | US FAERS | |
| 776 | Therapeutic product effect decreased | FAERS: 1 | US FAERS | |
| 777 | Therapy partial responder | FAERS: 1 | US FAERS | |
| 778 | Throat cancer | FAERS: 1 | US FAERS | |
| 779 | Thrombocytosis | FAERS: 1 | US FAERS | |
| 780 | Tinnitus | FAERS: 1 | US FAERS | |
| 781 | Tooth Extraction | FAERS: 1 | US FAERS | |
| 782 | Traumatic fracture | FAERS: 1 | US FAERS | |
| 783 | Trigeminal Neuralgia | FAERS: 1 | US FAERS | |
| 784 | Tuberculosis | FAERS: 1 | US FAERS | |
| 785 | Ureteral stent insertion | FAERS: 1 | US FAERS | |
| 786 | Urinary tract stoma complication | FAERS: 1 | US FAERS | |
| 787 | Urine output increased | FAERS: 1 | US FAERS | |
| 788 | Vaginal mucosal blistering | FAERS: 1 | US FAERS | |
| 789 | Vagus Nerve Disorder | FAERS: 1 | US FAERS | |
| 790 | Vascular compression | FAERS: 1 | US FAERS | |
| 791 | Venous thrombosis limb | FAERS: 1 | US FAERS | |
| 792 | Ventricular hypokinesia | FAERS: 1 | US FAERS | |
| 793 | Vertebral column mass | FAERS: 1 | US FAERS | |
| 794 | Viral sinusitis | FAERS: 1 | US FAERS | |
| 795 | Viral upper respiratory tract infection | FAERS: 1 | US FAERS | |
| 796 | Vitreous floaters | FAERS: 1 | US FAERS | |
| 797 | Vulvovaginal dryness | FAERS: 1 | US FAERS | |
| 798 | Vulvovaginal erythema | FAERS: 1 | US FAERS | |
| 799 | Walking aid user | FAERS: 1 | US FAERS | |
| 800 | Wound dehiscence | FAERS: 1 | US FAERS | |
| 801 | Xerophthalmia | FAERS: 1 | US FAERS | |
| 802 | Xerosis | FAERS: 1 | US FAERS | |
| 803 | effusion | FAERS: 1 | US FAERS | |
| 804 | heart rate | FAERS: 1 | US FAERS | |
| 805 | intensive care | FAERS: 1 | US FAERS | |
| 806 | ovarian neoplasm | FAERS: 1 | US FAERS | |
| 807 | prostatitis | FAERS: 1 | US FAERS | |
| 808 | skin abrasion | FAERS: 1 | US FAERS | |
| 809 | Abdominal Infection | Canada Vigilance: 1 | Canada Vigilance | |
| 810 | Acute Coronary Syndrome | SIDER | ||
| 811 | Adenocarcinoma | Canada Vigilance: 1 | Canada Vigilance | |
| 812 | Anorectal infection | Canada Vigilance: 1 | Canada Vigilance | |
| 813 | Apparent death | Canada Vigilance: 1 | Canada Vigilance | |
| 814 | Bile duct stent insertion | Canada Vigilance: 2 | Canada Vigilance | |
| 815 | Blood albumin increased | Canada Vigilance: 1 | Canada Vigilance | |
| 816 | Blood and lymphatic system disorders | SIDER | ||
| 817 | Blood blister | Canada Vigilance: 1 | Canada Vigilance | |
| 818 | Blood glucose fluctuation | Canada Vigilance: 1 | Canada Vigilance | |
| 819 | Blood iron increased | Canada Vigilance: 1 | Canada Vigilance | |
| 820 | Blood magnesium abnormal | Canada Vigilance: 1 | Canada Vigilance | |
| 821 | Blood magnesium increased | Canada Vigilance: 1 | Canada Vigilance | |
| 822 | Blood phosphorus increased | Canada Vigilance: 1 | Canada Vigilance | |
| 823 | Chemotherapy | Canada Vigilance: 1 | Canada Vigilance | |
| 824 | Cold sweat | Canada Vigilance: 1 | Canada Vigilance | |
| 825 | Concomitant disease aggravated | Canada Vigilance: 1 | Canada Vigilance | |
| 826 | Cyst | Canada Vigilance: 1 | Canada Vigilance SIDER | |
| 827 | Device leakage | Canada Vigilance: 1 | Canada Vigilance | |
| 828 | Emotional disorder | Canada Vigilance: 1 | Canada Vigilance | |
| 829 | Enzyme level increased | Canada Vigilance: 1 | Canada Vigilance | |
| 830 | Expired product administered | Canada Vigilance: 1 | Canada Vigilance | |
| 831 | Eye laser surgery | Canada Vigilance: 1 | Canada Vigilance | |
| 832 | Facial wasting | Canada Vigilance: 1 | Canada Vigilance | |
| 833 | Fracture pain | Canada Vigilance: 1 | Canada Vigilance | |
| 834 | Gastroenteritis | SIDER | ||
| 835 | Genital burning sensation | Canada Vigilance: 1 | Canada Vigilance | |
| 836 | Hypokinesia | Canada Vigilance: 1 | Canada Vigilance | |
| 837 | Infestation | SIDER | ||
| 838 | Inguinal mass | Canada Vigilance: 1 | Canada Vigilance | |
| 839 | Intracranial mass | Canada Vigilance: 1 | Canada Vigilance | |
| 840 | Joint warmth | Canada Vigilance: 1 | Canada Vigilance | |
| 841 | Lipase abnormal | SIDER | ||
| 842 | Metastases to thorax | Canada Vigilance: 1 | Canada Vigilance | |
| 843 | Myositis | Canada Vigilance: 1 | Canada Vigilance | |
| 844 | Nail bed tenderness | Canada Vigilance: 1 | Canada Vigilance | |
| 845 | Nasal discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 846 | Necrosis | 25445804 | CTD | |
| 847 | Onychalgia | Canada Vigilance: 1 | Canada Vigilance | |
| 848 | Oropharyngeal candidiasis | Canada Vigilance: 1 | Canada Vigilance | |
| 849 | Pain management | Canada Vigilance: 1 | Canada Vigilance | |
| 850 | Palliative Care | Canada Vigilance: 31 | Canada Vigilance | |
| 851 | Pancreatic enzymes abnormal | Canada Vigilance: 1 | Canada Vigilance | |
| 852 | Perineal pain | Canada Vigilance: 1 | Canada Vigilance | |
| 853 | Post procedural discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 854 | Product administered to patient of inappropriate age | Canada Vigilance: 1 | Canada Vigilance | |
| 855 | Pulmonary thrombosis | Canada Vigilance: 1 | Canada Vigilance | |
| 856 | Purulent discharge | Canada Vigilance: 1 | Canada Vigilance | |
| 857 | Radiotherapy to stomach | Canada Vigilance: 1 | Canada Vigilance | |
| 858 | Recurrence | 25605917 | CTD | |
| 859 | Reflux gastritis | Canada Vigilance: 1 | Canada Vigilance | |
| 860 | Sinus pain | Canada Vigilance: 1 | Canada Vigilance | |
| 861 | Somnambulism | Canada Vigilance: 1 | Canada Vigilance | |
| 862 | Spinal cord infection | Canada Vigilance: 1 | Canada Vigilance | |
| 863 | Squamous cell carcinoma | SIDER | ||
| 864 | Supportive care | Canada Vigilance: 1 | Canada Vigilance | |
| 865 | Tachyarrhythmia | Canada Vigilance: 1 | Canada Vigilance | |
| 866 | Taste Disorders | SIDER | ||
| 867 | Toxic Epidermal Necrolysis | SIDER | ||
| 868 | Traumatic liver injury | SIDER | ||
| 869 | Vulvovaginal pain | Canada Vigilance: 1 | Canada Vigilance | |
| 870 | Wrong dose | Canada Vigilance: 1 | Canada Vigilance | |
| 871 | keratoacanthoma | SIDER |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.